Document is current
Any future updates will be listed below
-
Authors
Pierneef, Louise
van Hooij, Anouk
de Jong, Danielle
Wassenaar, Gaby
Verhard, Els
Tjon Kon Fat, Elisa
Engel, Nadine
Khatun, Marufa
Soren, Santosh
Chowdhury, Abu Sufian
van Hees, Colette
Corstjens, Paul
Geluk, Annemieke
-
Funding
Funding for this research was provided by:
Q.M. Gastmann-Wichers Stichting
- License Information
-
More Information
Article History
Received: 22 July 2024
Accepted: 14 November 2024
First Online: 2 December 2024
Declarations
:
: Ethical permission was received from national and local ethical boards: leprosy patient samples (Bangladesh Medical Research Council; Ref no. BMRC/NREC/2010-2013/1534 and MEC-2012-589, the Netherlands), leishmaniasis (MEC 2012-047 & MEC-2015-306 & B21.048, the Netherlands), TB (METC P07.048, the Netherlands), NTM (METC P207/99, the Netherlands) and BU samples (FWA00001824; Ghana). The BCG-CORONA trial was registered at clinicaltrials.gov (identifier: NCT04328441) and the Dutch Trial Registry (trialregister.nl, identifier Trial NL8477) and the study protocol was approved by the IRB of the LUMC (NL73249.041.20). The studies were conducted in accordance with local legislation and institutional requirements. All participants gave broad consent.
: Not applicable.
: The authors declare that they have no competing interests.
